| Description |
1 online resource (x, 79 pages) : illustrations |
| Contents |
Cover -- Contents -- 1. The Earliest Carefully Controlled Clinical Trial Evaluating Oral Pharmacotherapy (Yohimbine) in ED -- 1.1 Key Trial References -- 1.2 Importance of Study -- 1.3 Study Design -- 1.4 Key Results -- 1.5 Conclusions from Original Reports -- 1.6 Strengths -- 1.7 Weaknesses -- 1.8 Relevance -- 2. A Description of the Pioneering Work That Led to the First Approved Agents for ED: Giles Brindley, the Needle, and the Penis (Phenoxybenzamine) -- 2.1 Key Trial References -- 2.2 Importance of Study -- 2.3 Study Design -- 2.4 Key Results -- 2.5 Conclusions from Original Reports -- 2.6 Strengths -- 2.7 Weaknesses -- 2.8 Relevance -- 3. The Pivotal Study Showing That Intracorporal Injection of Vasoactive Agents (Papaverine or Phenoxybenzamine) Was Effective Pharmacotherapy -- 3.1 Key Trial References -- 3.2 Importance of Study -- 3.3 Study Design -- 3.4 Key Results -- 3.5 Conclusions from Original Reports -- 3.6 Strengths -- 3.7 Weaknesses -- 3.8 Relevance -- 4. The First Placebo-Controlled Study on the Benefits of Intracorporal Administration of Vasorelaxant Agents to ED Patients (Papaverine/Phentolamine Combination) -- 4.1 Key Trial References -- 4.2 Importance of Study -- 4.3 Study Design -- 4.4 Key Results -- 4.5 Conclusions from Original Reports -- 4.6 Strengths -- 4.7 Weaknesses -- 4.8 Relevance -- 5. Representative Study on the Use of Yohimbine in the Treatment of Organic ED -- 5.1 Key Trial References -- 5.2 Importance of Study -- 5.3 Study Design -- 5.4 Key Results -- 5.5 Conclusions from Original Reports -- 5.6 Strengths -- 5.7 Weaknesses -- 5.8 Relevance -- 6. Defining the Therapeutic Ratio for Intracavernosal Administration of Prostaglandin E<sub>1</sub> (Alprostadil) -- 6.1 Key Trial References -- 6.2 Study Funding -- 6.3 Importance of Study -- 6.4 Study Design -- 6.5 Key Results -- 6.6 Conclusions from Original Reports -- 6.7 Strengths -- 6.8 Weaknesses -- 6.9 Relevance -- 7. An Elegant Long-Term Trial Assessing the Clinical Profile of Intracavernosal Prostaglandin E<sub>1</sub> (Alprostadil) -- 7.1 Key Trial References -- 7.2 Importance of Study -- 7.3 Study Design -- 7.4 Key Results -- 7.5 Conclusions from Original Reports -- 7.6 Strengths -- 7.7 Weaknesses -- 7.8 Relevance -- 8. Evaluation of Novel Combination (Vasoactive Intestinal Polypeptide and Phentolamine) as Intracavernosal Therapy -- 8.1 Key Trial References -- 8.2 Study Funding -- 8.3 Importance of Study -- 8.4 Study Design -- 8.5 Key Results -- 8.6 Conclusions from Original Reports -- 8.7 Strengths -- 8.8 Weaknesses -- 8.9 Relevance -- 9. Now-Classic Study on the Use of Intraurethral Prostaglandin E<sub>1</sub> (Alprostadil) -- 9.1 Key Trial References -- 9.2 Study Funding -- 9.3 Importance of Study -- 9.4 Study Design -- 9.5 Key Results -- 9.6 Conclusions from Original Reports -- 9.7 Strengths -- 9.8 Weaknesse |
| Summary |
"This book represents a critical appraisal of the major clinical trials that have had a significant impact on clinical research and practice during the last decade. Each trial follows a strict format, starting with reference to the original source of publication, details on the key investigators and their methods of research. The strengths and weaknesses of each trial are discussed, as well as their influence on clinical practice. This is the first book to bring together in a single volume a critical review of all the major trials in ED." "Key Clinical Trials in Erectile Dysfunction is a reference for both clinicians and research workers in urology, sexual dysfunction and related disorders."--Jacket |
| Analysis |
geneeskunde |
|
medicine |
|
volksgezondheid |
|
public health |
|
geschiedenis |
|
history |
|
urinestelsel |
|
urinary system |
|
Medicine (General) |
|
Geneeskunde (algemeen) |
| Bibliography |
Includes bibliographical references and index |
| Notes |
Print version record |
| In |
Springer e-books |
| Subject |
Impotence -- Chemotherapy -- Abstracts
|
|
Clinical trials -- Abstracts
|
|
Clinical trials.
|
|
Erectile Dysfunction -- history
|
|
Clinical Trials as Topic -- history
|
|
Vasodilator Agents -- history
|
|
HEALTH & FITNESS -- Infertility.
|
|
Clinical trials.
|
|
Impotence -- History.
|
|
Clinical Trials -- History.
|
|
Vasodilator Agents -- History.
|
|
Impotence -- Chemotherapy.
|
|
Clinical trials
|
|
Impotence -- Chemotherapy
|
| Genre/Form |
Abstracts
|
|
Abstracts.
|
|
Résumés analytiques.
|
| Form |
Electronic book
|
| ISBN |
9781846284281 |
|
1846284287 |
|
9781846284274 |
|
1846284279 |
|
6610817359 |
|
9786610817351 |
|
